Global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 80 tables and 89 figures, this 196-page report “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pre-filled Syringes
• Multidose Eyedroppers
• Squeeze Dispensers
• Mist Sprayers
• Contact Lenses
• Ocular Inserts
• Intraocular Implants
• Punctal Plugs
• Other Products
Based on Dosage Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Solutions
• Gels
• Ointments
• Suspensions
• Emulsions
• Liposomes & Nanoparticles
By Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Glaucoma
• Diabetic Retinopathy
• Cataract
• Dry Eye Syndrome
• Macular Degeneration
• Diabetic Macular Edema
• Refractive Issues
• Other Diseases
By Setting, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
• Other Settings
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Israel, UAE，Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Dosage Form and Setting over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aero Pump GmbH
Allergan plc.
AptarGroup, Inc.
Becton, Dickinson and Company
Biocorp
Clearside Biomedical, Inc.
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer AG
Jotteq Inc.
Kedalion Therapeutics, Inc.
Mati Therapeutics, Inc.
Nemera
Nipro Corporation
Ocular Therapeutix, Inc.
Ocumedic, Inc.
Owen Mumford
Re-Vana Therapeutics
Silgan Holdings Inc.
Terumo Corporation
Valeant Pharmaceuticals International Inc. (Bausch Health Company)
West Pharmaceutical Services, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter’s Fiver Forces Analysis 38
3 Segmentation of Global Market by Product 42
3.1 Market Overview by Product 42
3.2 Pre-filled Syringes 44
3.3 Multidose Eyedroppers 45
3.4 Squeeze Dispensers 46
3.5 Mist Sprayers 47
3.6 Contact Lenses 48
3.7 Ocular Inserts 49
3.8 Intraocular Implants 50
3.9 Punctal Plugs 51
3.10 Other Products 52
4 Segmentation of Global Market by Dosage Form 53
4.1 Market Overview by Dosage Form 53
4.2 Solutions 55
4.3 Gels 56
4.4 Ointments 57
4.5 Suspensions 58
4.6 Emulsions 59
4.7 Liposomes & Nanoparticles 60
5 Segmentation of Global Market by Disease 61
5.1 Market Overview by Disease 61
5.2 Glaucoma 63
5.3 Diabetic Retinopathy 64
5.4 Cataract 65
5.5 Dry Eye Syndrome 66
5.6 Macular Degeneration 67
5.7 Diabetic Macular Edema 68
5.8 Refractive Issues 69
5.9 Other Diseases 70
6 Segmentation of Global Market by Setting 71
6.1 Market Overview by Setting 71
6.2 Hospitals 73
6.3 Clinics 74
6.4 Homecare Settings 75
6.5 Ambulatory Surgical Centers (ASCs) 76
6.6 Other Settings 77
7 Segmentation of Global Market by Region 78
7.1 Geographic Market Overview 2021-2031 78
7.2 North America Market 2021-2031 by Country 82
7.2.1 Overview of North America Market 82
7.2.2 U.S. 86
7.2.3 Canada 90
7.2.4 Mexico 93
7.3 European Market 2021-2031 by Country 96
7.3.1 Overview of European Market 96
7.3.2 Germany 100
7.3.3 U.K. 103
7.3.4 France 106
7.3.5 Spain 109
7.3.6 Italy 112
7.3.7 Netherlands 115
7.3.8 Rest of European Market 118
7.4 Asia-Pacific Market 2021-2031 by Country 120
7.4.1 Overview of Asia-Pacific Market 120
7.4.2 Japan 124
7.4.3 China 128
7.4.4 Australia 131
7.4.5 India 134
7.4.6 South Korea 137
7.4.7 Rest of APAC Region 140
7.5 South America Market 2021-2031 by Country 142
7.5.1 Argentina 145
7.5.2 Brazil 148
7.5.3 Chile 151
7.5.4 Rest of South America Market 154
7.6 MEA Market 2021-2031 by Country 155
7.6.1 Israel 158
7.6.2 Saudi Arabia 161
7.6.3 South Africa 164
7.6.4 Other National Markets 167
8 Competitive Landscape 168
8.1 Overview of Key Vendors 168
8.2 New Product Launch, Partnership, Investment, and M&A 172
8.3 Company Profiles 173
Aero Pump GmbH 173
Allergan plc. 175
AptarGroup, Inc. 176
Becton, Dickinson and Company 177
Biocorp 178
Clearside Biomedical, Inc. 179
EyePoint Pharmaceuticals, Inc. 180
Gaplast GmbH 181
Gerresheimer AG 182
Jotteq Inc. 183
Kedalion Therapeutics, Inc. 184
Mati Therapeutics, Inc. 185
Nemera 186
Nipro Corporation 187
Ocular Therapeutix, Inc. 188
Ocumedic, Inc. 189
Owen Mumford 190
Re-Vana Therapeutics 191
Silgan Holdings Inc. 192
Terumo Corporation 193
Valeant Pharmaceuticals International Inc. (Bausch Health Company) 194
West Pharmaceutical Services, Inc. 195
RELATED REPORTS 196
List of Tables:
Table 1. Snapshot of Global Ophthalmic Drug Delivery System Market in Balanced Perspective, 2021-2031 20
Table 2. World Economic Outlook, 2021-2031 25
Table 3. Main Product Trends and Market Opportunities in Global Ophthalmic Drug Delivery System Market 35
Table 4. Global Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 43
Table 5. Global Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 54
Table 6. Global Ophthalmic Drug Delivery System Market by Disease, 2021-2031, $ mn 62
Table 7. Global Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 72
Table 8. Global Ophthalmic Drug Delivery System Market by Region, 2021-2031, $ mn 80
Table 9. Leading National Ophthalmic Drug Delivery System Market, 2021 and 2031, $ mn 82
Table 10. North America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 85
Table 11. U.S. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 89
Table 12. U.S. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 89
Table 13. U.S. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 90
Table 14. Canada Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 92
Table 15. Canada Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 92
Table 16. Canada Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 93
Table 17. Mexico Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 95
Table 18. Mexico Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 95
Table 19. Mexico Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 96
Table 20. Europe Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 100
Table 21. Germany Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 102
Table 22. Germany Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 102
Table 23. Germany Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 103
Table 24. U.K. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 105
Table 25. U.K. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 105
Table 26. U.K. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 106
Table 27. France Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 108
Table 28. France Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 108
Table 29. France Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 109
Table 30. Spain Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 111
Table 31. Spain Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 111
Table 32. Spain Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 112
Table 33. Italy Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 114
Table 34. Italy Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 114
Table 35. Italy Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 115
Table 36. Netherlands Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 117
Table 37. Netherlands Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 117
Table 38. Netherlands Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 118
Table 39. Ophthalmic Drug Delivery System Market in Rest of Europe by Country, 2021-2031, $ mn 120
Table 40. APAC Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 123
Table 41. Japan Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 127
Table 42. Japan Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 127
Table 43. Japan Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 128
Table 44. China Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 130
Table 45. China Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 130
Table 46. China Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 131
Table 47. Australia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 133
Table 48. Australia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 133
Table 49. Australia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 134
Table 50. India Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 136
Table 51. India Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 136
Table 52. India Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 137
Table 53. South Korea Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 139
Table 54. South Korea Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 139
Table 55. South Korea Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 140
Table 56. Ophthalmic Drug Delivery System Market in Rest of APAC by Country/Region, 2021-2031, $ mn 142
Table 57. South America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 145
Table 58. Argentina Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 147
Table 59. Argentina Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 147
Table 60. Argentina Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 148
Table 61. Brazil Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 150
Table 62. Brazil Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 150
Table 63. Brazil Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 151
Table 64. Chile Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 153
Table 65. Chile Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 153
Table 66. Chile Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 154
Table 67. MEA Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 158
Table 68. Israel Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 160
Table 69. Israel Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 160
Table 70. Israel Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 161
Table 71. Saudi Arabia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 163
Table 72. Saudi Arabia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 163
Table 73. Saudi Arabia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 164
Table 74. South Africa Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 166
Table 75. South Africa Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 166
Table 76. South Africa Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 167
Table 77. Breakdown of World Market by Key Vendor, 2021, % 171
Table 78. Aero Pump GmbH: Company Snapshot 174
Table 79. Aero Pump GmbH: Business Segmentation 175
Table 80. Aero Pump GmbH: Product Portfolio 175
